CMO Maricich Yuri buys 6,060 shares at $1.65; 6 insiders bought in past 14 days as stock surges 101.4% in 30 days.
Maricich Yuri, Chief Medical Officer, purchased 6,060 shares at $1.65 on 2025-09-11, establishing a new position of 6,060 shares with a transaction value of $9,999.00. This buy is part of a cluster pattern: 6 other insiders also purchased shares within the past 14 days, suggesting coordinated conviction at a specific price level. The timing is notable given recent price action—the stock has risen 101.4% in the past 30 days and 80.5% in the past 90 days, yet is still 76.3% below its 52-week high of $11.74, indicating recovery from a significantly depressed level. The company remains unprofitable (net income $-12.6M in the latest fiscal year), though revenue growth has been strong at 86.3% annually. The cluster buy pattern coinciding with sharp recent gains suggests insiders perceive the recovery as substantive rather than speculative, but investors should note the company's ongoing losses and whether this climb reflects durable operational progress or temporary momentum.